Wallez, Y., Dunlop, C. R., Johnson, T. I., Koh, S., Fornari, C., Yates, J. W., . . . Jodrell, D. I. (2018). The ATR inhibitor AZD6738 synergizes with gemcitabine in vitro and in vivo to induce pancreatic ductal adenocarcinoma regression. Mol Cancer Ther.
Styl ChicagoWallez, Yann, et al. "The ATR Inhibitor AZD6738 Synergizes With Gemcitabine in Vitro and in Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression." Mol Cancer Ther 2018.
Citace podle MLAWallez, Yann, et al. "The ATR Inhibitor AZD6738 Synergizes With Gemcitabine in Vitro and in Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression." Mol Cancer Ther 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..